[go: up one dir, main page]

MX9202642A - MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN MELANOMA. - Google Patents

MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN MELANOMA.

Info

Publication number
MX9202642A
MX9202642A MX9202642A MX9202642A MX9202642A MX 9202642 A MX9202642 A MX 9202642A MX 9202642 A MX9202642 A MX 9202642A MX 9202642 A MX9202642 A MX 9202642A MX 9202642 A MX9202642 A MX 9202642A
Authority
MX
Mexico
Prior art keywords
antigen
monoclonal antibodies
human melanoma
melanoma
human
Prior art date
Application number
MX9202642A
Other languages
Spanish (es)
Inventor
Ingegerd Hellstrom
Karl Erik Hellstrom
Hans Marquardt
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX9202642A publication Critical patent/MX9202642A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX9202642A 1991-06-05 1992-06-03 MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN MELANOMA. MX9202642A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71061391A 1991-06-05 1991-06-05

Publications (1)

Publication Number Publication Date
MX9202642A true MX9202642A (en) 1992-12-01

Family

ID=24854790

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202642A MX9202642A (en) 1991-06-05 1992-06-03 MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN MELANOMA.

Country Status (7)

Country Link
AU (1) AU2170692A (en)
IE (1) IE921810A1 (en)
IL (1) IL102088A0 (en)
MX (1) MX9202642A (en)
PT (1) PT100568A (en)
WO (1) WO1992021767A1 (en)
ZA (1) ZA924068B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10505481A (en) 1994-04-22 1998-06-02 アメリカ合衆国 Melanoma antigen
US5874560A (en) * 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
AT502292B1 (en) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology MELANOMA DIAGNOSIS
US20110300067A1 (en) * 2008-09-09 2011-12-08 Ekaterina Dadachova Methods for increasing efficacy of radioimmunotherapy of melanoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339798C (en) * 1985-02-01 1998-04-07 Alan N. Houghton Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans
GB2188637B (en) * 1986-02-07 1990-11-14 Oncogen Vaccines against melanoma

Also Published As

Publication number Publication date
IE921810A1 (en) 1992-12-16
AU2170692A (en) 1993-01-08
WO1992021767A1 (en) 1992-12-10
ZA924068B (en) 1993-02-24
IL102088A0 (en) 1993-01-14
PT100568A (en) 1993-09-30

Similar Documents

Publication Publication Date Title
DE69225757D1 (en) LYOPHILIC MONOCLONAL ANTIBODY PREPARATIONS
DK666389D0 (en) MONOCLONAL ANTIBODY
FI933328L (en) ANTIGEN-PRODUCING PROTEIN
FI913891A7 (en) A novel monoclonal antibody against a novel antigen associated with human tumors
DE68914244D1 (en) Monoclonal antibody.
DE69232604D1 (en) ANTIBODY CONSTRUCTS
NO955167L (en) Monoclonal anti-V integrin antibody
NO921863L (en) ANTIBODIES AND USES THEREOF
FI963004L (en) Monoclonal antibodies that stimulate antibody formation
FI960567L (en) Monoclonal antibody that induces apoptosis
DE3889062D1 (en) Monoclonal antibody against human BCDF.
ITRM920457A0 (en) MONOCLONAL ANTIBODIES THAT RECOGNIZE AN EPITOPE OF THE HUMAN P-GLYCOPROTEIN.
NO920523D0 (en) IGE-RECEPTOR ANTIBODY
NO894444D0 (en) ANTI-FUCOSYL CERAMIDE MONOCLONAL ANTIBODY.
MX9202642A (en) MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN MELANOMA.
DE69129582D1 (en) ANTIBODIES AGAINST HUMAN PLASMIN-ALPHA 2-PLASMININHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY
FI934963A7 (en) CTAA 81AV78, antigen recognized by the 81AV78 human monoclonal antibody
NO890116D0 (en) MONOCLONAL ANTIBODIES.
FI945485L (en) Monoclonal antibodies and their use
DE69023717D1 (en) Monoclonal antibody.
FI925638A7 (en) Monoclonal antibody directed against an antigen associated with tumors 88BV59
FI893928A7 (en) MONOCLONAL ANTIBODIES.
DE69020315D1 (en) MONOCLONAL ANTIBODY AGAINST C-REACTIVE PROTEIN.
FI935038A7 (en) Tumor-associated monoclonal antibody 81AV78
BR9709080A (en) Human anti-MP52 monoclonal antibody